Clinical Scorecard: Glaucoma Trials Tracker
At a Glance
| Category | Detail |
|---|---|
| Condition | Glaucoma |
| Key Mechanisms | Intraocular pressure reduction through various interventions including medications, surgical techniques, and devices. |
| Target Population | Patients with open-angle glaucoma or ocular hypertension, including those with refractory cases. |
| Care Setting | Clinical trials across various healthcare institutions. |
Key Highlights
- Multiple trials evaluating new treatments for intraocular pressure reduction.
- Focus on both pharmacological and surgical interventions.
- Involvement of various sponsors including AbbVie, Glaukos Corporation, and Bausch + Lomb.
Guideline-Based Recommendations
Diagnosis
- Diagnosis of glaucoma should include assessment of intraocular pressure, visual field testing, and optic nerve evaluation.
Management
- Consider both medical and surgical options based on the severity and type of glaucoma.
Monitoring & Follow-up
- Regular follow-up to monitor intraocular pressure and visual field changes.
Risks
- Potential risks include progression of glaucoma, side effects from medications, and complications from surgical interventions.
Patient & Prescribing Data
Adults with open-angle glaucoma or ocular hypertension.
Emerging therapies include fixed-dose combinations and novel surgical techniques.
Clinical Best Practices
- Utilize a multidisciplinary approach for managing glaucoma patients.
- Incorporate patient education regarding treatment options and adherence.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.